ArticleFrontiers in public health2026
Is health financing converging in the European Union? Nonlinear dynamics and policy implications for non-euro area member states.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Convergence in health expenditure across European Union (EU) member states is central to health system equity, fiscal sustainability, and regional cohesion. However, whether countries operating outside the euro area are moving toward similar levels of per capita health spending remains unclear, particularly in the presence of economic shocks and institutional heterogeneity. Methods: This study investigates stochastic convergence in per capita health expenditure among seven EU member states outside the euro area over the period 2000-2022. Using nonlinear and structural-break-sensitive time-series approaches, we assess whether deviations from the group average are temporary or persistent, allowing for asymmetric adjustment and regime shifts. Results: The findings indicate that health expenditure convergence is neither linear nor uniform across countries. While more fiscally mature and institutionally stable systems exhibit evidence of nonlinear long-run adjustment, several countries display persistent divergence from the group mean. At the panel level, results suggest gradual and cyclical convergence rather than steady alignment. Adjustment dynamics appear sensitive to macroeconomic crises and policy environments, highlighting asymmetric responses during expansionary and contractionary periods. Conclusion: Health expenditure convergence among EU countries outside the euro area is best understood as a nonlinear and context-dependent process. Persistent divergence in some countries may pose risks for health system equity and resilience, particularly during economic downturns. These findings underscore the importance of adaptive and counter-cyclical health financing strategies at both national and EU levels to promote sustainable convergence and reduce structural disparities in health system capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.